• AIKAWA, R., KOMURO, I., YAMAZAKI, T., ZOU, Y., KUDOH, S., TANAKA, M., SHIOJIMA, I., HIROI, Y. & YAZAKI, Y. (1997). Oxidative stress activates extracellular signal-regulated kinases through Src and Ras in cultured cardiac myocytes of neonatal rats. J. Clin. Invest., 105, 18131821.
  • AOKI, H., KANG, P.M., HAMPE, J., YOSHIMURA, K., NOMA, T., MATSUZAKI, M. & IZUMO, S. (2002). Direct activation of mitochondrial apoptosis machinery by c-Jun N-terminal kinase in adult cardiac myocytes. J. Biol. Chem., 277, 1024410250.
  • ARMSTRONG, S.C. (2004). Protein kinase activation and myocardial ischemia/reperfusion injury. Cardiovasc. Res., 61, 427436.
  • BALLER, D., BRETSCHNEIDER, H.J. & HELLIGE, G. (1981). A critical look at currently used indirect indices of myocardial oxygen consumption. Basic Res. Cardiol., 76, 163181.
  • BARLING, B., HOLTZ, J. & DARMER, D. (1998). Contribution of myocyte apoptosis to myocardial infarction? Basic Res. Cardiol., 93, 7184.
  • BOGOYEVITCH, M.A., GILLESPIE-BROWN, J., KETTERMAN, A.J., FULLER, S.J., BEN-LEVY, R., ASHWORTH, A., MARSHALL, C.J. & SUGDEN, P.H. (1996). Stimulation of the stress-activated mitogen-activated protein kinase subfamilies in perfused heart. P38/RK mitogen-activated protein kinases and c-Jun N-terminal kinases are activated by ischemia/reperfusion. Circ. Res., 79, 162173.
  • BUTTERFIELD, L., ZENTRICH, E., BEEKMAN, A. & HEASLEY, L.E. (1999). Stress and cell type dependent regulation of transfected c-Jun N-terminal kinase and mitogen-activated protein kinase kinase isoforms. Biochem. J., 338, 681686.
  • CARBONI, S., HIVER, A., SZYNDRALEWIEZ, C., GAILLARD, P., GOTTELAND, J.P. & VITTE, P.A. (2004). AS601245: a inhibitor with neuroprotective properties. J. Pharmacol. Exp. Ther., 310 (1).
  • CHIARUGI, A. (2002). Poly(ADP-ribose)polymerase: killer or conspirator? The ‘suicide hypothesis’ revisited. Trends Pharmacol. Sci., 3, 122129.
  • CLERK, A., FULLER, S.J., MICHAEL, A. & SUGDEN, P.H. (1998). Stimulation of ‘stress-regulated’ mitogen-activated protein kinase (stress-activated protein kinases/c-Jun N-terminal kinases and p38-mitogen-activated protein kinases) in perfused rat hearts by oxidative and other stresses. J. Biol. Chem., 273, 72287234.
  • COOK, S.A., SUGDEN, P.H. & CLERK, A. (1999). Activation of c-Jun N-terminal kinases and p38-mitogen-activated protein kinases in human heart failure secondary to ischemic heart disease. J. Mol. Cell. Cardiol., 31, 14291434.
  • GOTTLIEB, R.A., BURLESON, K.O., KLONER, R.A., BABIOR, B.M. & ENGLER, R.L. (1994). Reperfusion injury induces apoptosis in rabbit cardiomyocytes. J. Clin. Invest., 94, 16211628.
  • GUPTA, S., BARRET, T., WHITMARSH, A.J., CAVANAGH, J., SLUSS, H.K., DERIJARD, B. & DAVIS, R.J. (1996). Selective interaction of JNK protein kinase isoforms with transcription factors. EMBO J., 15, 27602770.
  • HRENIUK, D., GARAY, M., GAARDE, W., MONIA, B.P., MCKAY, R.A. & CIOFFI, C.L. (2001). Inhibition of c-Jun N-terminal kinase 1, but c-Jun N-terminal kinase 2, suppresses apoptosis induced by ischemia/reoxygenation in rat cardiac myocytes. Mol. Pharmacol., 59, 867874.
  • KNIGHT, R.J. & BUXTON, D.B. (1996). Stimulation of c-Jun kinase and mitogen-activated protein kinase by ischemia and reperfusion in the reperfused rat heart. Biochem. Biophys. Res. Commun., 218, 8388.
  • LADEROUTE, K.R. & WEBSTER, K.A. (1997). Hypoxia/reoxygenation stimulates Jun kinase activity through redox signaling in cardiac myocytes. Circ. Res., 80, 336344.
  • LIAUDET, L., SZABO, E., TIMASHPOLSKY, L., VIRAG, L., CZIRAKI, A. & SZABO, C. (2001). Suppression of poly (ADP-ribose) polymerase activation by 3-aminobenzamide in a rat model of myocardial infarction: long-term morphological and functional consequences. Br. J. Pharmacol., 133, 14241430.
  • OLIVETTI, G., ABBI, R., QUAINI, F., KAJSTURA, J., CHENG, W., NITAHARA, J.A., QUAINI, E., DI LORETO, C., BELTRAMI, C.A., KRAJEWSKI, S., REED, J.C. & ANVERSA, P. (1997). Apoptosis in the failing human heart. N. Engl. J. Med., 336, 11311141.
  • SCHUMANN, H., MORAWIEZ, H., HAKIM, K., ZERKOWSKI, H.R., ESCHENHAGEN, T., HOLTZ, J. & DARMER, D. (1997). Alternative spicing of the primary Fas transcript generating soluble Fas antagonists is suppressed in the failing human ventricular myocardium. Biochem. Biophys. Res. Comm., 239, 794798.
  • SUGDEN, P.H. & CLERK, A. (1998). ‘Stress-responsive’ mitogen-activated protein kinases (c-Jun N-terminal kinases and p38 mitogen-activated protein kinases) in the myocardium. Circ. Res., 83, 345352.
  • YIN, T., SANDHU, G., WOLFGANG, C.D., WEBB, R.L., RIGEL, D.F., HAI, T. & WHELAN, J. (1997). Tissue-specific pattern of stress kinase activation in ischemic/reperfused heart and kidney. J. Biol. Chem., 272, 1994319950.
  • YUE, T.L., WANG, X.K., LOUDEN, C.S., WOLFGANG, C.D., BURRIER, A., WEBB, R., RIGEL, D.F., HAI, T. & WHELAN, J. (1997). 2-Methoxyestradiol, an endogenous estrogen metabolite, induces apoptosis in endothelial cells and inhibits angiogenesis: possible role for stress-activated protein kinase signaling pathway and Fas expression. Mol. Pharmacol., 51, 951962.
  • ZACHAROWSKI, K., OLBRICH, A., OTTO, M., HAFNER, G. & THIEMERMANN, C. (1999). Effects of the prostanoid EP3-receptor agonists M&B 28767 and GR 63799X on infarct size caused by regional myocardial ischaemia in the anaestetized rat. Br. J. Pharmacol., 126, 849858.